3D Medicines Inc.
1244.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$587.75M
Close$
Share Statistics
| Market cap | $587.75 Million |
|---|---|
| Enterprise Value | $613.62 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.72 |
| Beta | 0.25 |
| Outstanding Shares | 245,921,000 |
Return
| Return on Equity | -65.16% |
|---|---|
| Return on Assets | -36.48% |
| Return on Invested Capital | -80.21% |
Valuation & Multiples
| P/E Ratio | -2.87 |
|---|---|
| PEG | 63.59 |
| Price to Sales | 0.87 |
| Price to Book Ratio | 2.6 |
| Enterprise Value to Revenue | 0.76 |
| Enterprise Value to EBIT | -1.58 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About 3D Medicines Inc.
162 employees
CEO: Zhaolong Gong Established in 2014 and headquartered in Qingdao, China, 3D Medicines Inc. is a biopharmaceutical company dedicated to the discovery, development, and market introduction of innovative oncology drugs and therapeutic candidates. Its core ...